“…Importantly, a prolonged rise in baseline
could have an essential part in disease development by boosting the production and toxicity of
's in cells with AD‐related disorders. These mutually beneficial regulations, in which
promotes a
increase, which in turn raises the level of
, create a positive feedback loop that is expected to create a vicious circle leading to disease development [
8, 13, 40]. Inspired by this fact and using clinical data such as study data from the ADNI database (http://adni.loni.usc.edu), we developed and tested a simple novel stochastic model to predict the interplay between the
and
concentrations on AD progression in a clinical trial.…”